APA
Montalbán C., Abraira V., Arcaini L., Domingo-Domenech E., Guisado-Vasco P., Iannitto E., Iannito E., Mollejo M., Matutes E., Ferreri A., Salar A., Rattotti S., Carpaneto A., Pérez Fernández R., Bello J. L., Hernández M., Caballero D., Carbonell F. & Piris M. A. (20121217). Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. : British journal of haematology.
Chicago
Montalbán Carlos, Abraira Víctor, Arcaini Luca, Domingo-Domenech Eva, Guisado-Vasco Pablo, Iannitto Emilio, Iannito Emilio, Mollejo Manuela, Matutes Estella, Ferreri Andrés, Salar Antonio, Rattotti Sara, Carpaneto Andrea, Pérez Fernández Ricardo, Bello José L, Hernández Miguel, Caballero Dolores, Carbonell Felix and Piris Miguel A. 20121217. Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. : British journal of haematology.
Harvard
Montalbán C., Abraira V., Arcaini L., Domingo-Domenech E., Guisado-Vasco P., Iannitto E., Iannito E., Mollejo M., Matutes E., Ferreri A., Salar A., Rattotti S., Carpaneto A., Pérez Fernández R., Bello J. L., Hernández M., Caballero D., Carbonell F. and Piris M. A. (20121217). Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. : British journal of haematology.
MLA
Montalbán Carlos, Abraira Víctor, Arcaini Luca, Domingo-Domenech Eva, Guisado-Vasco Pablo, Iannitto Emilio, Iannito Emilio, Mollejo Manuela, Matutes Estella, Ferreri Andrés, Salar Antonio, Rattotti Sara, Carpaneto Andrea, Pérez Fernández Ricardo, Bello José L, Hernández Miguel, Caballero Dolores, Carbonell Felix and Piris Miguel A. Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. : British journal of haematology. 20121217.